Wynzora

Active Ingredient(s): Betamethasone Dipropionate + Calcipotriene
FDA Approved: * July 20, 2020
Pharm Company: * MC2
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Wynzora Overview

Calcipotriol/betamethasone dipropionate, sold under the brand name Taclonex among others, is a fixed-dose combination medication of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis.[3][4][5] It is used in the form of ointment, topical suspension, gel, aerosol, and foam.[2][3][4 ...

Read more Wynzora Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Betamethasone/calcipotriol

Recent Wynzora Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Betamethasone Dipropionate + Calcipotriene
  • Aerosol, Foam: 0.064% + 0.005%
  • Cream: 0.064% + 0.005%
  • Foam: 0.005% + 0.064%
  • Ointment: 0.064% + 0.005%
  • Suspension: 0.064% + 0.005%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (9 results)